Accenture Up on Partnership with Anthropic; Novo Nordisk Falls on Turnaround | Stock Movers
On this episode of Stock Movers: - Novo Nordisk (NVO) shares are lower as it disappointed investors hoping for concrete turnaround plans from Chief Executive Officer Mike Doustdar after losing its lead in the obesity market to Eli Lilly & Co. The…
Read the full story at Bloomberg Markets ↗
ImpactNotable 35/100
Why it mattersRule-based estimate: no strong signals; trust 9/10.
RegionsGlobal
Published5 h ago (Mon, 21 Sep 2026 14:49:08 GMT)
RetrievedMon, 21 Sep 2026 17:00:53 GMT via rss
ClassifiedMon, 21 Sep 2026 18:01:24 GMT by heuristic